Benzinga
02 Mar 2026, 17:30 UTC · 29w ago
Verdict
Headline leans bearish. We score ELV −1.00 across four claims.
Score confirms the headline.
Leans bearish
From its wording — no explicit rating
−1.00strongly bearish
What the story claims
4 claims · scored −1 bearish … +1 bullish
CMS intends to freeze enrollment of Medicare beneficiaries into Elevance Health's Medicare Advantage-Prescription Drug plans starting March 31, 2026.
More negative than 99% of claims this week
Elevance Health's fiscal 2026 adjusted earnings guidance of at least $25.50 per share is below the Wall Street estimate of $26.90.
So whatLowered earnings expectations typically lead to a valuation markdown by analysts.
Continue reading
5 related stories
More negative than 95% of ticker scores this week
Scored by the NIS engine · methodology.
More negative than 91% of claims this week
Elevance Health forecasts a mid-single digit decline in sales for 2026 due to lower premiums.
More negative than 86% of claims this week
Proposed CMS payment policy updates for 2027 suggest a net average payment increase of 0.09%, significantly lower than the expected 4%-6%.
So whatSubstantially lower-than-expected government reimbursement rates squeeze margins across the Medicare Advantage sector.
More negative than 78% of claims this week
Which stocks this story touches
More negative than 95% of ticker scores this week
CMS is freezing Medicare Advantage enrollment due to noncompliance, and the company provided bleak fiscal 2026 guidance leading to a significant stock price drop.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
+25.8%
Price is moving against the score
$402.43 vs $320.00 close before publication (Feb 27) · not market-adjusted
ELV chart →